April 27, 2026 Regeneron Joins Major Drugmakers in Pricing Concessions Under Trump Agreements for New and Existing Medicines
April 25, 2026 FDA Accelerates Psychedelic Drug Review with Priority Review Vouchers for Compass, Usona and Transcend in Mental Health Push
April 24, 2026 How Kelonia Therapeutics Went From Near Bankruptcy to a $3.25B Lilly Acquisition — and What It Means for Biotech M&A and Telehealth Partnerships
